Emapalumab Clinical Trials
6 recruitingDrug
Phase 25Phase 11
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
Immune System DiseasesPrimary Immune Regulatory DisorderAutoimmune Lymphoproliferative
Joseph Oved39 enrolled13 locationsNCT05787574
Recruiting
Phase 2
A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia
Cytopenia
M.D. Anderson Cancer Center32 enrolled1 locationNCT06285825
Recruiting
Phase 1
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Acute Myeloid LeukemiaMyelodysplastic SyndromeGraft-Versus-Host Disease
City of Hope Medical Center15 enrolled1 locationNCT06996119
Recruiting
Phase 2
A Study of Emapalumab for Pediatric Aplastic Anemia
Aplastic AnemiaCytopeniaHypocellular Marrow
Memorial Sloan Kettering Cancer Center35 enrolled6 locationsNCT06430788
Recruiting
Phase 2
Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis
National Institute of Allergy and Infectious Diseases (NIAID)10 enrolled1 locationNCT07202598
Recruiting
Phase 2
Emapalumab Prevention of CAR-T Cell Associated Toxicities
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaFollicular Lymphoma+4 more
Marcela V. Maus, M.D.,Ph.D.28 enrolled2 locationsNCT06550141